VOLATYLIX INC

Cambridge, MA · Medtech · Private

Microfluidic gas chromatography-differential mobility spectrometry (GC-DMS) breath analysis device for noninvasive diagnosis of invasive aspergillosis

Grants
$6.3M
5 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · A Rapid Breath Test for Invasive Aspergillosis$300,000
Federal grantDepartment of Health and Human Services · Phase II · A Rapid Breath Test for Invasive Aspergillosis$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · A Rapid Breath Test for Invasive Aspergillosis$3,000,000
Federal grantDepartment of Health and Human Services · Phase II · A Rapid Breath Test for Invasive Aspergillosis$1,000,000
Federal grantDepartment of Health and Human Services · Phase II · A Rapid Breath Test for Invasive Aspergillosis$1,000,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1501Artin Bioscience Inc.—$483K
1502Eye Care International LLC—$2.1M
1503Persist Inc.—$30K
1504VOLATYLIX INC——
1505Mozarc Medical Management Holding LLC—$22M
1506GENTURI, INC.——
1507Onnix Global Inc.—$30M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Integrated oscillating field ION spectrometry device and method of using the sameapplication
  • Integrated Oscillating Field Ion Spectrometry Device And Method Of Using The Sameapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.